Chemical synthesis of 16 beta-propylaminoacyl derivatives of estradiol andtheir inhibitory potency on type 1 17 beta-hydroxy steroid dehydrogenase and binding affinity on steroid receptors
Mr. Tremblay et al., Chemical synthesis of 16 beta-propylaminoacyl derivatives of estradiol andtheir inhibitory potency on type 1 17 beta-hydroxy steroid dehydrogenase and binding affinity on steroid receptors, STEROIDS, 66(11), 2001, pp. 821-831
The 17 beta -hydroxysteroid dehydrogenases (17 beta -HSDs) are members of a
family of enzymes that catalyze the interconversion of weakly active sexua
l hormones (ketosteroids) and potent hormones (17 beta -hydroxysteroids). A
mong the known isoforms of 17 beta -HSD, the type I catalyzes the NAD(P)H-m
ediated reduction of estrone (E-1) to estradiol (E-2), a predominant mitoge
n for the breast cancer cells. Therefore, the inhibition of this particular
enzyme is a logical approach to reduce the concentration of estradiol in b
reast tumors. To develop inhibitors of type 1 17 beta -HSD activity, we hyp
othesized that molecules containing both hydrophobic and hydrophilic compon
ents should be interesting candidates for interacting with both the steroid
binding domain and some amino acid residues of the cofactor binding domain
of the enzyme. Firstly, a conveniently protected 16 beta-(3-aminopropyl)-E
-2 derivative was synthesized from commercially available E-1. Then, a repr
esentative of all class of NHBoc-protected amino acids (basic, acid, aromat
ic, aliphatic, hydroxylated) were coupled using standard procedures to the
amino group of the precursor. Finally, cleavage of all protecting groups wa
s performed in a single step to generate a series of 16 beta -propylaminoac
yl derivatives of E-2. The enzymatic screenings revealed that none of the n
ovel compounds can inhibit the reductive activity of type 1 17 beta -HSD. O
n the other hand, all of these E-2 derivatives did not show any significant
binding affinity on four steroid receptors including the estrogen receptor
. Additional efforts aimed at improving the inhibitory potency of these ste
roidal derivatives on type 1 17 beta -HSD without providing estrogenic acti
vities is under investigation using a combinatorial chemistry approach. (C)
2001 Elsevier Science Inc. All rights reserved.